Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Gazyvaro“
Suchtreffer
Begriffe & Kennungen
Gazyvaro · 4.8 · In study MO40597, assessing the safety of SDI, thrombocytopenia was reported as an adverse event in a higher p
Eintrag öffnenGazyvaro · 4.8 · In the Gazyvaro plus chemotherapy arm, the incidence of Grade 1-4 neutropenia (50%) was higher relative to the
Eintrag öffnenGazyvaro · 4.8 · In the pivotal BO21004/CLL11 study, 27% (90 out of 336) of patients treated with Gazyvaro plus chlorambucil ha
Eintrag öffnenGazyvaro · 4.8 · In the pivotal BO21004/CLL11 study, 46% (156 out of 336) of patients with CLL treated with Gazyvaro plus chlor
Eintrag öffnenGazyvaro · 4.8 · In the pivotal studies (BO21223/GALLIUM, GAO4753g/GADOLIN) in iNHL, 5% (35 out of 698) and 7% (14 out of 204)
Eintrag öffnenGazyvaro · 4.8 · In the pivotal studies (BO21223/GALLIUM, GAO4753g/GADOLIN) in iNHL, patients 65 years or older experienced mor
Eintrag öffnenGazyvaro · 4.8 · Indolent Non Hodgkin Lymphoma including Follicular Lymphoma
Eintrag öffnenGazyvaro · 4.8 · Indolent Non-Hodgkin Lymphoma including Follicular Lymphoma
Eintrag öffnenGazyvaro · 4.8 · Infections
Eintrag öffnenGazyvaro · 4.8 · Infections were reported in 72.0% of patients in the Gazyvaro arm vs. 61.7% of patients in the placebo arm. Th
Eintrag öffnenGazyvaro · 4.8 · Infusion related reactions
Eintrag öffnenGazyvaro · 4.8 · Infusion-related reactions
Eintrag öffnenGazyvaro · 4.8 · Laboratory abnormalities
Eintrag öffnenGazyvaro · 4.8 · Lupus nephritis
Eintrag öffnenGazyvaro · 4.8 · Most frequently reported (≥ 5%) symptoms associated with an IRR were nausea, vomiting, diarrhoea, headache, di
Eintrag öffnenGazyvaro · 4.8 · Neutropenia
Eintrag öffnenGazyvaro · 4.8 · Neutropenia and related events were reported in 14.0% of patients in the Gazyvaro arm vs 6.2% of patients in t
Eintrag öffnenGazyvaro · 4.8 · Obinutuzumab treatment resulted in a decrease in total immunoglobulins in pooled LN data from placebo-controll
Eintrag öffnenGazyvaro · 4.8 · Renal impairment
Eintrag öffnenGazyvaro · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnen